EXHIBIT 10.2


                            AGREEMENT


This Agreement, made effective November 1, 1996, by and between
AAM Group, Inc. ("AAM") and Biomune Systems, Inc., a Nevada
Corporation ("Biomune");

NOW THEREFORE, the parties agree as follows:

     1.   Engagement, Duties and Acceptance.

          1.1  Engagement by Biomune.  Biomune hereby agrees to
               retain AAM for the following purposes:
               (a)  Provide introductions to potential business
                    partners;
               (b)  Provide introductions and information to and
                    about potential business partners.

          1.2  Acceptance of Engagement by AAM.  AAM hereby
               accepts such engagement and shall render
               management services as described above.

     2.   Term of Agreement.   The term of AAM's engagement under
          this Agreement (the "Term") shall commence on November
          1, 1996 (the "Commencement Date") and shall continue
          through and expire on the 30th day of March, 1997,
          unless sooner terminated by either Biomune or AAM upon
          thirty (30) days written notice.  This Agreement may
          continue in effect beyond the Term if mutually agreed
          in writing by both Biomune and AAM.

     3.   Compensation.  As compensation for services to be
          rendered pursuant to this Agreement, Biomune shall pay
          AAM Group, Inc. 30,000 shares of Biomune common stock
          that will be registered pursuant to an S-8 registration
          statement.

     4.   Confidential Information.  During the Term of this
          Agreement and for a period of five (5) years after the
          termination of this Agreement, AAM shall keep secret
          and retain in strictest confidence and shall not use,
          for the benefit of itself or others, all confidential
          matters of the Biomune including, without limitation,
          "know-how", trade secrets, customer lists, details of
          client or consultant contracts, pricing policies,
          operational methods, marketing plans or strategies,
          product development techniques or plans, methods of
          production and distribution, technical processes,
          designs and design projects, inventions and research
          projects of Biomune learned by AAM heretofore or during
          the Term hereof.

     5.   Other Provisions.

     5.1  Any notice or other communication required or permitted
          hereunder shall be in writing and shall be delivered
          personally, telegraphed, telexed, sent by facsimile
          transmission or sent by certified, registered or
          express mail, postage prepaid. Any such notice shall be
          deemed given when so delivered personally, telegraphed,
          telexed or sent by facsimile ransmission or, if mailed,
          five days after the date of deposit in the United
          States mail, as follows:

               (i)  if to Biomune, to:

                    Biomune Systems, Inc.
                    2401 South Foothill Drive
                    Salt Lake City, Utah  
                    84109

                    with a copy to:

                    Nolan Taylor, Esquire
                    LeBoeuf, Lamb, Greene & MacRae
                    1000 Kearns Building
                    136 South Main Street
                    Salt Lake City, Utah  
                    84101

               (ii) if to AAM, to:

                    AAM Group, Inc.
                    100 Daly Blvd. Unite 2807
                    Oceanside, New York
                    11572


     5.2  Entire Agreement.  This Agreement contains the entire
          agreement between the parties with respect to the
          subject matter hereof and supersedes all prior
          agreement, written or oral, with respect thereto.

     5.3  Governing Law; Venue.  This Agreement shall be governed
          and construed in accordance with the laws of the State
          of Utah applicable to agreements made and to be
          performed entirely within such state.  The parties
          submit themselves to the jurisdiction of the federal
          and state courts located in Utah and agree to commence
          any lawsuit arising under or relating to this Agreement
          in such courts.

     5.4  Assignment.  This Agreement, and any rights and
          obligations hereunder, may not be assigned by any party
          hereto without the prior written consent of the other
          party.

     5.5  Headings.  The headings in this Agreement are for
          reference purposes only and shall not in any way affect
          the meaning or interpretation of this Agreement.


IN WITNESS WHEREOF, the parties have executed this Agreement
effective as of the date first above-written.


     BIOMUNE SYSTEMS, INC.


By:     /s/ Michael G. Acton
Its:    Chief Financial Officer

     AAM GROUP, INC.


By:     /s/ Adam Krisftcher
Its:    President